Nagendra Govindappa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nagendra Govindappa has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
Veeranjaneyulu Avula
Department of Chemistry REVA University, Rukmini Knowledge Park Kattigenahalli Yelahanka Bangalore 560064 Karnataka India
5 shared publications- Dalli Kumari
Department of Chemistry, REVA University, Rukmini Knowledge Park, Kattigenahalli, Yelahanka, Bangalore, 560064, Karnataka, India
4 shared publications - Haraluru Shankaraiah Lalithamba
Department of Chemistry, Siddaganga Institute of Technology, Tumkur, India
4 shared publications Aisha Siddekha
Department of Chemistry, Government First Grade College, B.H. Road, Tumakuru, Karnataka, India
3 shared publicationsH. S. Lalithamba
Siddaganga Institute of Technology, Tumakuru, India
3 shared publicationsM. Ramya
Department of Chemistry, Reva University, Bangalore, India
3 shared publications
Latest Publications
- 11 November 2026
- Published by Bentham Science Publishers Ltd. in Current Science, Engineering and Technology
- Vol. 06
Synthesis, Electrical, Antioxidant, and Enhanced Photocatalytic Activity Studies on NiO-ZrO2-CdO Mixed Metal Oxide Nanocomposite
Introduction: This study primarily focused on evaluating the photodegradation capabilities of the nanocomposite NiO-ZrO2-CdO with respect to methylene blue, and we also investigated the antioxidant properties of the nanocomposite. Methods: The NiO-ZrO2-CdO nanocomposite was synthesised using a solution combustion method and characterised by XRD, SEM, TEM, EDX, UV-DRS, and photoluminescence techniques. Results: The results indicated a photodegradation efficiency of 68% for methylene blue, highlighting the effectiveness of the nanocomposite in degrading organic contaminants under UV light conditions. We compared the photodegradation efficiency of the nanocomposite NiOZrO2- CdO with NiO-ZrO2 and NiO-CdO. Discussion: The nanocomposite demonstrated superior dye degradation performance compared to its bimetallic counterparts (NiO-ZrO2 and NiO-CdO). The nanocomposite also exhibited significant antioxidant activity with an inhibition rate of 59.99 ± 2.2% at a nanoparticle concentration of 25 μg/mL. The nanocomposite had an IC50 of 39.40 ± 1.59, highlighting its effectiveness in biological systems. Conclusion: Overall, the synthesized NiO-ZrO2-CdO nanocomposite shows good photodegradation efficiency and antioxidant properties.
- 11 November 2026
- Published by Bentham Science Publishers Ltd. in Current Science, Engineering and Technology
- Vol. 06
Synthesis, Electrical, Antioxidant, and Enhanced Photocatalytic Activity Studies on NiO-ZrO2-CdO Mixed Metal Oxide Nanocomposite
Introduction: This study primarily focused on evaluating the photodegradation capabilities of the nanocomposite NiO-ZrO2-CdO with respect to methylene blue, and we also investigated the antioxidant properties of the nanocomposite. Methods: The NiO-ZrO2-CdO nanocomposite was synthesised using a solution combustion method and characterised by XRD, SEM, TEM, EDX, UV-DRS, and photoluminescence techniques. Results: The results indicated a photodegradation efficiency of 68% for methylene blue, highlighting the effectiveness of the nanocomposite in degrading organic contaminants under UV light conditions. We compared the photodegradation efficiency of the nanocomposite NiOZrO2- CdO with NiO-ZrO2 and NiO-CdO. Discussion: The nanocomposite demonstrated superior dye degradation performance compared to its bimetallic counterparts (NiO-ZrO2 and NiO-CdO). The nanocomposite also exhibited significant antioxidant activity with an inhibition rate of 59.99 ± 2.2% at a nanoparticle concentration of 25 μg/mL. The nanocomposite had an IC50 of 39.40 ± 1.59, highlighting its effectiveness in biological systems. Conclusion: Overall, the synthesized NiO-ZrO2-CdO nanocomposite shows good photodegradation efficiency and antioxidant properties.
- Open Access
- 3 November 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (41) , e75034
De Novo Design, Synthesis, In Silico, and Anticancer Studies of N α ‐Fmoc/Cbz‐Amino Acid Derived 2‐Amino‐1,3,4‐thiadiazines
The present work reveals an optimized protocol for the synthesis of novel six‐membered 2‐amino‐1,3,4‐thiadiazine derivatives of N α ‐protected amino acids, using N α ‐Fmoc/Cbz‐amino acid‐derived bromoketone in conjunction with thiosemicarbazide. In silico studies highlighted promising interactions for the anticancer proteins EGFR and MMP‐9 of 10 compounds (4a–4j) synthesized. Compound 4e showed a significant docking score of −8.4 kcal/mol and compound 4j scored −7.9 kcal/mol for EGFR. Additionally, compound 4e exhibited a strong binding affinity of −9.2 kcal/mol, and compound 4j scored −8.7 kcal/mol for MMP‐9. Overall, the synthesized 2‐amino‐1,3,4‐thiadiazines (4a–4j) demonstrate encouraging interactions for potential cancer therapy.
- 3 November 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (41) , e75034
Open AccessDe Novo Design, Synthesis, In Silico, and Anticancer Studies of N α ‐Fmoc/Cbz‐Amino Acid Derived 2‐Amino‐1,3,4‐thiadiazines
The present work reveals an optimized protocol for the synthesis of novel six‐membered 2‐amino‐1,3,4‐thiadiazine derivatives of N α ‐protected amino acids, using N α ‐Fmoc/Cbz‐amino acid‐derived bromoketone in conjunction with thiosemicarbazide. In silico studies highlighted promising interactions for the anticancer proteins EGFR and MMP‐9 of 10 compounds (4a–4j) synthesized. Compound 4e showed a significant docking score of −8.4 kcal/mol and compound 4j scored −7.9 kcal/mol for EGFR. Additionally, compound 4e exhibited a strong binding affinity of −9.2 kcal/mol, and compound 4j scored −8.7 kcal/mol for MMP‐9. Overall, the synthesized 2‐amino‐1,3,4‐thiadiazines (4a–4j) demonstrate encouraging interactions for potential cancer therapy.
- Open Access
- 15 September 2026
- Published by International Union of Crystallography (IUCr) in IUCrData
- Vol. 11 (9) , x260927
5-Cyclopropyl-1-[(4-methylbenzene)sulfonyl]indole-2-carbaldehyde
The crystal structure of the title compound, C 19 H 17 NO 3 S, was determined by single-crystal X-ray diffraction. The compound crystallizes in the monoclinic crystal system with space group P 2 1 / c . The indole ring is essentially planar, with cyclopropyl, aldehyde and p -toluenesulfonyl groups attached at the C5, C2 and N1 positions, respectively. The aldehyde substituent is nearly coplanar with the indole ring, while the cyclopropyl and p -tolyl rings are almost perpendicular to it. The crystal packing is mainly influenced by slipped π–π stacking interactions, along with weak C—H...O interactions involving the sulfonyl oxygen atoms. Hirshfeld surface analysis shows that H...H (46.6%), O...H/H...O (23.5%), C...H/H...C (16.0%) and C...C (8.0%) contacts make the major contributions to the crystal packing.
- 15 September 2026
- Published by International Union of Crystallography (IUCr) in IUCrData
- Vol. 11 (9) , x260927
Open Access5-Cyclopropyl-1-[(4-methylbenzene)sulfonyl]indole-2-carbaldehyde
The crystal structure of the title compound, C 19 H 17 NO 3 S, was determined by single-crystal X-ray diffraction. The compound crystallizes in the monoclinic crystal system with space group P 2 1 / c . The indole ring is essentially planar, with cyclopropyl, aldehyde and p -toluenesulfonyl groups attached at the C5, C2 and N1 positions, respectively. The aldehyde substituent is nearly coplanar with the indole ring, while the cyclopropyl and p -tolyl rings are almost perpendicular to it. The crystal packing is mainly influenced by slipped π–π stacking interactions, along with weak C—H...O interactions involving the sulfonyl oxygen atoms. Hirshfeld surface analysis shows that H...H (46.6%), O...H/H...O (23.5%), C...H/H...C (16.0%) and C...C (8.0%) contacts make the major contributions to the crystal packing.
- Open Access
- 24 June 2026
- Published by Elsevier in SSRN Electronic Journal
Design, Synthesis and In-silico Studies of Hydrophobic Anti-Allergic Peptides Assisted by TAGGING Technique
The design and synthesis of novel antiallergic peptides (15–24) using hydrophobic TAG-assisted solution-phase peptide synthesis, which enables straightforward purification and synthesis, are presented in the current study. The synthesis of peptide sequences facilitated by this TAGGING technique yields N-terminally modified peptides that also permit structural modifications to improve stability and bioactivity. To evaluate the binding affinity of the synthetic peptides to important targets implicated in allergic pathways, such as IgE receptors and histamine-related mediators, in silico studies, interaction analysis, and molecular docking were performed. Additionally, the physicochemical, toxicological, allergenic, and stability properties of the peptides were predicted using computational methods. The TAGGED peptides were used to determine the binding or docking capacity of the synthesised peptides in the enzymes. The results indicate that better binding interactions, increased stability, and decreased potential toxicity.
- 24 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDesign, Synthesis and In-silico Studies of Hydrophobic Anti-Allergic Peptides Assisted by TAGGING Technique
The design and synthesis of novel antiallergic peptides (15–24) using hydrophobic TAG-assisted solution-phase peptide synthesis, which enables straightforward purification and synthesis, are presented in the current study. The synthesis of peptide sequences facilitated by this TAGGING technique yields N-terminally modified peptides that also permit structural modifications to improve stability and bioactivity. To evaluate the binding affinity of the synthetic peptides to important targets implicated in allergic pathways, such as IgE receptors and histamine-related mediators, in silico studies, interaction analysis, and molecular docking were performed. Additionally, the physicochemical, toxicological, allergenic, and stability properties of the peptides were predicted using computational methods. The TAGGED peptides were used to determine the binding or docking capacity of the synthesised peptides in the enzymes. The results indicate that better binding interactions, increased stability, and decreased potential toxicity.
- 15 April 2026
- Published by The Electrochemical Society in Journal of the Electrochemical Society
- Vol. 173 (8) , 087501
Fmoc-Phe-oPDA/Zr-MOF Coated Carbon Fiber for Electrochemical Detection of Chloramphenicol and Furazolidone Residues in Food Samples
Zr-based metal–organic frameworks (Zr-MOFs) hybridized with carbon fiber materials have emerged as effective platforms for advanced electrochemical interfaces due to their high surface area and favorable charge-transfer property. In this work, Fmoc-Phe-oPDA (FPP) was synthesized and systematically characterized using mass spectrometry, 1 H NMR, XRD, SEM, and FTIR spectroscopy. The prepared FPP was hybridized with Zr-MOF and carbon fiber to prepare a Fmoc-Phe-oPDA@Zr-MOF/CF modified glassy carbon electrode (FPP@Zr-MOF/CF/GCE). The FPP@Zr-MOF/CF/GCE electrode exhibited enhanced electrocatalytic activity toward chloramphenicol (CAP) and furazolidone (FZ), attributed to the synergistic interaction between the porous Zr-MOF architecture, peptide functionality, and conductive carbon fiber network. Electrochemical studies revealed high sensitivities of 1.0 μA μM −1 cm −2 for both CAP and FZ, with detection limits of 4.5 μM and 0.56 μM, respectively. The simultaneous detection of CAP and FZ exhibited excellent repeatability, stability, reproducibility, and selectivity against potential interfering species. Furthermore, the applicability of the developed electrode was validated through the successful determination of CAP and FZ in real food samples, yielding satisfactory recoveries. The results highlight the effectiveness of FPP@Zr-MOF/CF as a robust electrochemical interface, providing insights into the rational design of peptide–MOF–carbon-based electrocatalytic systems for analytical and sensing applications.
- 15 April 2026
- Published by The Electrochemical Society in Journal of the Electrochemical Society
- Vol. 173 (8) , 087501
Fmoc-Phe-oPDA/Zr-MOF Coated Carbon Fiber for Electrochemical Detection of Chloramphenicol and Furazolidone Residues in Food Samples
Zr-based metal–organic frameworks (Zr-MOFs) hybridized with carbon fiber materials have emerged as effective platforms for advanced electrochemical interfaces due to their high surface area and favorable charge-transfer property. In this work, Fmoc-Phe-oPDA (FPP) was synthesized and systematically characterized using mass spectrometry, 1 H NMR, XRD, SEM, and FTIR spectroscopy. The prepared FPP was hybridized with Zr-MOF and carbon fiber to prepare a Fmoc-Phe-oPDA@Zr-MOF/CF modified glassy carbon electrode (FPP@Zr-MOF/CF/GCE). The FPP@Zr-MOF/CF/GCE electrode exhibited enhanced electrocatalytic activity toward chloramphenicol (CAP) and furazolidone (FZ), attributed to the synergistic interaction between the porous Zr-MOF architecture, peptide functionality, and conductive carbon fiber network. Electrochemical studies revealed high sensitivities of 1.0 μA μM −1 cm −2 for both CAP and FZ, with detection limits of 4.5 μM and 0.56 μM, respectively. The simultaneous detection of CAP and FZ exhibited excellent repeatability, stability, reproducibility, and selectivity against potential interfering species. Furthermore, the applicability of the developed electrode was validated through the successful determination of CAP and FZ in real food samples, yielding satisfactory recoveries. The results highlight the effectiveness of FPP@Zr-MOF/CF as a robust electrochemical interface, providing insights into the rational design of peptide–MOF–carbon-based electrocatalytic systems for analytical and sensing applications.
- 13 March 2026
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 33
A Computational Strategy to Identify Hub Genes in Pathway Analysis of Gamma Tocotrienol-treated MCF-7 Cells and Molecular Docking Study Using Selected Phytochemicals as Therapeutic Agents
Introduction: Breast cancer is a highly prevalent malignancy in women, necessitating the discovery of novel therapeutic approaches. Researchers have focused on various medicinal plants for their therapeutic benefits, including anti-carcinogenic properties. These plants are abundant in nature, generally safe, cost-effective, and exhibit lower toxicity compared to currently available synthetic cancer treatments. Materials and Methods: This study employed a bioinformatic approach to identify potential biomarkers and signaling pathways. Analysis of Gene Expression Omnibus (GEO) dataset GSE21946 (Gamma tocotrienol-treated MCF-7 cells) revealed 250 differentially expressed genes (DEGs), including 175 upregulated and 75 downregulated genes. Gene ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses identified significant functional pathways and candidate genes. Protein- protein interaction (PPI) network analysis further revealed four key gene candidates: EGR1, JUN, SREBF1, and TGIF1. Results: This study also evaluated the identification of potent bioactive compounds through computational screening of 10 phytochemicals with established anticancer properties to inform the development of effective breast cancer therapies. Using the SwissADME and admetSAR online servers, these phytochemicals were assessed for pharmacokinetic properties and pharmacophore features. Discussion: Docking studies were conducted with the four hub gene targets. The results indicated that Quercetin (-6.1 to -7.7 Kcal/mol) and Kaempferol (-6.0 to -7.3 Kcal/mol) exhibited the highest negative binding affinities and strongest H-bond interactions with all four targeted proteins when compared to FDA-approved standard drugs Alpelisib, Capivasertib, Elacestrant, and Silibinin. Conclusion: These findings may facilitate the development of traditional medicinebased therapeutic strategies and provide insights for potential lead optimization in breast cancer drug discovery.
- 13 March 2026
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 33
A Computational Strategy to Identify Hub Genes in Pathway Analysis of Gamma Tocotrienol-treated MCF-7 Cells and Molecular Docking Study Using Selected Phytochemicals as Therapeutic Agents
Introduction: Breast cancer is a highly prevalent malignancy in women, necessitating the discovery of novel therapeutic approaches. Researchers have focused on various medicinal plants for their therapeutic benefits, including anti-carcinogenic properties. These plants are abundant in nature, generally safe, cost-effective, and exhibit lower toxicity compared to currently available synthetic cancer treatments. Materials and Methods: This study employed a bioinformatic approach to identify potential biomarkers and signaling pathways. Analysis of Gene Expression Omnibus (GEO) dataset GSE21946 (Gamma tocotrienol-treated MCF-7 cells) revealed 250 differentially expressed genes (DEGs), including 175 upregulated and 75 downregulated genes. Gene ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses identified significant functional pathways and candidate genes. Protein- protein interaction (PPI) network analysis further revealed four key gene candidates: EGR1, JUN, SREBF1, and TGIF1. Results: This study also evaluated the identification of potent bioactive compounds through computational screening of 10 phytochemicals with established anticancer properties to inform the development of effective breast cancer therapies. Using the SwissADME and admetSAR online servers, these phytochemicals were assessed for pharmacokinetic properties and pharmacophore features. Discussion: Docking studies were conducted with the four hub gene targets. The results indicated that Quercetin (-6.1 to -7.7 Kcal/mol) and Kaempferol (-6.0 to -7.3 Kcal/mol) exhibited the highest negative binding affinities and strongest H-bond interactions with all four targeted proteins when compared to FDA-approved standard drugs Alpelisib, Capivasertib, Elacestrant, and Silibinin. Conclusion: These findings may facilitate the development of traditional medicinebased therapeutic strategies and provide insights for potential lead optimization in breast cancer drug discovery.
- Open Access
- 20 February 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (12) , 11090-11099
Design, synthesis, molecular docking, and antimicrobial evaluation of hybrid peptides incorporating unnatural amino acids with enhanced hydrophobic sidechains
The emergence of multidrug-resistant (MDR) pathogens has intensified the need for novel antimicrobial agents. This study focuses on the design, synthesis, and evaluation of hybrid peptides (6a–6e) incorporating unnatural amino acids featuring enhanced hydrophobic side chains. These peptides, particularly 6e, demonstrated potent antimicrobial efficacy. Molecular docking identified the robust binding affinities of peptides 6e and 6b towards the transglycosylase domain of Escherichia coli PBP1b, indicating their potential as enzyme inhibitors. Molecular dynamics (MD) simulations confirmed the stability of peptide-protein complexes over a 100 ns timespan, supporting the structural integrity of peptide 6e. Experimental data further validated computational predictions, with peptide 6e exhibiting minimum inhibitory concentrations (MICs) as low as 2 µg mL−1 against E. coli and 0.2 µg mL−1 against Bacillus subtilis. Additionally, 6e demonstrated broad-spectrum antifungal efficacy, showing competitive activity against Candida albicans and Aspergillus niger. These results establish unnatural amino acid-based peptides as promising candidates in addressing MDR infections, warranting further studies for clinical application.
- 20 February 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (12) , 11090-11099
Open AccessDesign, synthesis, molecular docking, and antimicrobial evaluation of hybrid peptides incorporating unnatural amino acids with enhanced hydrophobic sidechains
The emergence of multidrug-resistant (MDR) pathogens has intensified the need for novel antimicrobial agents. This study focuses on the design, synthesis, and evaluation of hybrid peptides (6a–6e) incorporating unnatural amino acids featuring enhanced hydrophobic side chains. These peptides, particularly 6e, demonstrated potent antimicrobial efficacy. Molecular docking identified the robust binding affinities of peptides 6e and 6b towards the transglycosylase domain of Escherichia coli PBP1b, indicating their potential as enzyme inhibitors. Molecular dynamics (MD) simulations confirmed the stability of peptide-protein complexes over a 100 ns timespan, supporting the structural integrity of peptide 6e. Experimental data further validated computational predictions, with peptide 6e exhibiting minimum inhibitory concentrations (MICs) as low as 2 µg mL−1 against E. coli and 0.2 µg mL−1 against Bacillus subtilis. Additionally, 6e demonstrated broad-spectrum antifungal efficacy, showing competitive activity against Candida albicans and Aspergillus niger. These results establish unnatural amino acid-based peptides as promising candidates in addressing MDR infections, warranting further studies for clinical application.
- 23 January 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (2) , 304-311
Scalable Hydrophobic Tag-Assisted Convergent Synthesis of Cetrorelix Acetate
- 23 January 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (2) , 304-311
Scalable Hydrophobic Tag-Assisted Convergent Synthesis of Cetrorelix Acetate
- 8 January 2026
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 33
Synthesis of Enduracididine Free Linear Teixobactin Analogs: Molecular Docking, DFT Calculations, and Their Antimicrobial Activities, Bacterial Cell Wall Lysis and Glucose Assay
Introduction: Teixobactin (TX) is a new class of antibiotics with a unique structure and strong efficacy against gram-positive bacteria. It is a "head-to-side-chain" cyclodepsipeptide with considerable potential as a lead molecule for creating novel antibiotics to combat multidrug-resistant pathogens. Methods: In this study, we systematically design, synthesize, and evaluate modified Teixobactin analogs (TX1-TX5) for antimicrobial activity. This study presents a novel peptide derived from linearized Teixobactin, with amino acid substitutions at aa1 (N-Me-D-Phe-OH), aa5 (HL- allo-Ile-OH), and the exclusion of L-allo-Enduracididine at aa10, synthesized using solidphase peptide synthesis. We employed various software tools, including Molinspiration and SwissADME, to estimate the pharmacokinetic features of the synthesized TX analogs. Molecular docking studies were performed using AutoDock Vina, and PyMOL and Biovia Discovery Studio visualizer were utilized to visualize the protein-ligand interactions. The molecular structures of TX and TX analogs were modeled using the Sinapsis software. Results: Antimicrobial susceptibility tests against Staphylococcus aureus, Bacillus subtilis, E. coli, Pseudomonas sp., Aspergillus niger, and Fusarium sp. identified novel TX analogs exhibiting strong bactericidal and fungicidal activity at 80 μg/mL. Bacterial cell wall lysis assays confirmed significant cell wall breakdown upon TX analog treatment. Glucose assay results indicate reduced glucose uptake in bacterial cells treated with TX analogs. Docking studies revealed that the synthesized TX analogs exhibited good binding affinity, ranging from -5.0 to - 12.5 kcal/mol, compared with bacterial and fungal proteins, as well as the Delafloxacin and Ketoconazole standards. Density Functional Theory (DFT) computations were employed to investigate chemical reactivity descriptors. Discussion: In-vitro studies indicated that TX1 and TX3 showed excellent bactericidal activity by forming inhibition zone diameters (mm) from 6.49 ±0.31 to 11.50 ±0.59 at 70 and 80 μg/mL concentrations against Staphylococcus aureus, Bacillus subtilis, E. coli, and Pseudomonas sp., compared to the standards Streptomycin (+ve) and DMSO (-ve). The TX2, TX3, and TX5 exhibit excellent fungicidal activity with inhibition zone diameters (mm) from 7.23 ±0.25 to 10.23 ±0.30 at 70 and 80 μg/mL concentrations against Aspergillus niger and Fusarium sp., compared to the standards ketoconazole (+ve) and DMSO (-ve). The bacterial cells treated with TX1 displayed more dead cells than the control in all bacterial strains, indicating excellent cell lysis. Conclusion: Mass, 1H NMR, and HPLC analysis characterized the synthesized fine TX analogs (TX1-TX5). The DFT and docking studies' electronic characteristic calculations predicted that halogenated (TX1, TX2, and TX4) and methoxy (TX3) substituted analogs have higher stability and electrophilicity, making them suitable agents for antimicrobial activity.
- 8 January 2026
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 33
Synthesis of Enduracididine Free Linear Teixobactin Analogs: Molecular Docking, DFT Calculations, and Their Antimicrobial Activities, Bacterial Cell Wall Lysis and Glucose Assay
Introduction: Teixobactin (TX) is a new class of antibiotics with a unique structure and strong efficacy against gram-positive bacteria. It is a "head-to-side-chain" cyclodepsipeptide with considerable potential as a lead molecule for creating novel antibiotics to combat multidrug-resistant pathogens. Methods: In this study, we systematically design, synthesize, and evaluate modified Teixobactin analogs (TX1-TX5) for antimicrobial activity. This study presents a novel peptide derived from linearized Teixobactin, with amino acid substitutions at aa1 (N-Me-D-Phe-OH), aa5 (HL- allo-Ile-OH), and the exclusion of L-allo-Enduracididine at aa10, synthesized using solidphase peptide synthesis. We employed various software tools, including Molinspiration and SwissADME, to estimate the pharmacokinetic features of the synthesized TX analogs. Molecular docking studies were performed using AutoDock Vina, and PyMOL and Biovia Discovery Studio visualizer were utilized to visualize the protein-ligand interactions. The molecular structures of TX and TX analogs were modeled using the Sinapsis software. Results: Antimicrobial susceptibility tests against Staphylococcus aureus, Bacillus subtilis, E. coli, Pseudomonas sp., Aspergillus niger, and Fusarium sp. identified novel TX analogs exhibiting strong bactericidal and fungicidal activity at 80 μg/mL. Bacterial cell wall lysis assays confirmed significant cell wall breakdown upon TX analog treatment. Glucose assay results indicate reduced glucose uptake in bacterial cells treated with TX analogs. Docking studies revealed that the synthesized TX analogs exhibited good binding affinity, ranging from -5.0 to - 12.5 kcal/mol, compared with bacterial and fungal proteins, as well as the Delafloxacin and Ketoconazole standards. Density Functional Theory (DFT) computations were employed to investigate chemical reactivity descriptors. Discussion: In-vitro studies indicated that TX1 and TX3 showed excellent bactericidal activity by forming inhibition zone diameters (mm) from 6.49 ±0.31 to 11.50 ±0.59 at 70 and 80 μg/mL concentrations against Staphylococcus aureus, Bacillus subtilis, E. coli, and Pseudomonas sp., compared to the standards Streptomycin (+ve) and DMSO (-ve). The TX2, TX3, and TX5 exhibit excellent fungicidal activity with inhibition zone diameters (mm) from 7.23 ±0.25 to 10.23 ±0.30 at 70 and 80 μg/mL concentrations against Aspergillus niger and Fusarium sp., compared to the standards ketoconazole (+ve) and DMSO (-ve). The bacterial cells treated with TX1 displayed more dead cells than the control in all bacterial strains, indicating excellent cell lysis. Conclusion: Mass, 1H NMR, and HPLC analysis characterized the synthesized fine TX analogs (TX1-TX5). The DFT and docking studies' electronic characteristic calculations predicted that halogenated (TX1, TX2, and TX4) and methoxy (TX3) substituted analogs have higher stability and electrophilicity, making them suitable agents for antimicrobial activity.